Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5943)
All Articles published online
|
Oct 28, 2008 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Parfieniuk A, Flisiak R. Role of cannabinoids in chronic liver diseases. World J Gastroenterol 2008; 14(40): 6109-6114 [PMID: 18985799 DOI: 10.3748/wjg.14.6109] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i40/6109.htm |
| Number | Citing Articles |
| 1 |
Joseph B. Miller, Mark Walsh, Pankaj A. Patel, Michael Rogan, Cliff Arnold, Megan Maloney, Michael Donnino. Pediatric Cannabinoid Hyperemesis. Pediatric Emergency Care 2010; 26(12): 919 doi: 10.1097/PEC.0b013e3181fe9189
|
| 2 |
Anna Maria Malfitano, Elena Ciaglia, Giuseppina Gangemi, Patrizia Gazzerro, Chiara Laezza, Maurizio Bifulco. Update on the endocannabinoid system as an anticancer target. Expert Opinion on Therapeutic Targets 2011; 15(3): 297 doi: 10.1517/14728222.2011.553606
|
| 3 |
Rebekah Nash, Eric Golden, Mary Amanda Dew, Andrea F. DiMartini. Psychosocial Care of End-Stage Organ Disease and Transplant Patients. 2019; : 147 doi: 10.1007/978-3-319-94914-7_12
|
| 4 |
Botros Shenoda, Joseph Boselli. Vascular syndromes in liver cirrhosis. Clinical Journal of Gastroenterology 2019; 12(5): 387 doi: 10.1007/s12328-019-00956-0
|
| 5 |
Carmen M. Mitchell, Omar El Jordi, Bryan K. Yamamoto. Role of Inflammation in Environmental Neurotoxicity. Advances in Neurotoxicology 2019; 3: 133 doi: 10.1016/bs.ant.2018.10.006
|
| 6 |
Siwei Tan, Huiling Liu, Bilun Ke, Jie Jiang, Bin Wu. The peripheral CB1 receptor antagonist JD5037 attenuates liver fibrosis via a CB1 receptor/β‐arrestin1/Akt pathway. British Journal of Pharmacology 2020; 177(12): 2830 doi: 10.1111/bph.15010
|
| 7 |
Daniel Fuster, Xavier García-Calvo, Ferran Bolao, Paola Zuluaga, Gemma Rocamora, Anna Hernández-Rubio, Arantza Sanvisens, Jordi Tor, Robert Muga. Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment. Drug and Alcohol Dependence 2020; 216: 108231 doi: 10.1016/j.drugalcdep.2020.108231
|
| 8 |
Pratima Dibba, Andrew A. Li, George Cholankeril, Umair Iqbal, Chiranjeevi Gadiparthi, Muhammad Ali Khan, Donghee Kim, Aijaz Ahmed. The Role of Cannabinoids in the Setting of Cirrhosis. Medicines 2018; 5(2): 52 doi: 10.3390/medicines5020052
|
| 9 |
Yu-Jin Kwon, Ji-Hye Kim, Dong-Hyuk Jung. Association Between Nonalcoholic Fatty Liver Disease and Intraocular Pressure in Korean Adults. Journal of Glaucoma 2018; 27(12): 1099 doi: 10.1097/IJG.0000000000001036
|
| 10 |
Hemant Goyal, M. Rubayat Rahman, Abhilash Perisetti, Nihar Shah, Rajiv Chhabra. Cannabis in liver disorders: a friend or a foe?. European Journal of Gastroenterology & Hepatology 2018; 30(11): 1283 doi: 10.1097/MEG.0000000000001256
|
| 11 |
Munechika Enjoji, Motoyuki Kohjima, Kazuhiro Kotoh, Makoto Nakamuta. Metabolic Disorders and Steatosis in Patients with Chronic Hepatitis C: Metabolic Strategies for Antiviral Treatments. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/264017
|
| 12 |
|
| 13 |
|
| 14 |
P. P. Basu, M. M. Aloysius, N. J. Shah, R. S. Brown Jr. Review article: the endocannabinoid system in liver disease, a potential therapeutic target. Alimentary Pharmacology & Therapeutics 2014; 39(8): 790 doi: 10.1111/apt.12673
|
| 15 |
Part I: Current Legislation, Scientific Literature Review, and Nursing Implications. Journal of Nursing Regulation 2018; 9(2): S6 doi: 10.1016/S2155-8256(18)30083-8
|
| 16 |
Ismail Maulood. Hemodynamic ,thyroid and immunomodulater effects of cannabinoid in rats.. Journal of Zankoy Sulaimani - Part A 2016; 18(2): 71 doi: 10.17656/jzs.10505
|
| 17 |
Hedyeh Ebrahimi, Mohammadreza Naderian, Amir Ali Sohrabpour. New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article. Middle East Journal of Digestive Diseases 2018; 10(3): 133 doi: 10.15171/mejdd.2018.103
|
| 18 |
David van der Poorten, Mahsa Shahidi, Enoch Tay, Jayshree Sesha, Kayla Tran, Duncan McLeod, Jane S. Milliken, Vikki Ho, Lionel W. Hebbard, Mark W. Douglas, Jacob George, Jean-Pierre Vartanian. Hepatitis C Virus Induces the Cannabinoid Receptor 1. PLoS ONE 2010; 5(9): e12841 doi: 10.1371/journal.pone.0012841
|
| 19 |
Li-Jie Sun, Jian-Wu Yu, Lin Wan, Xiao-Yu Zhang, Yu-Guang Shi, Mo-Yang Chen. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication. International Journal of Infectious Diseases 2014; 23: 75 doi: 10.1016/j.ijid.2013.12.017
|
| 20 |
Eleonora Patsenker, Matthias Stoll, Gunda Millonig, Abbas Agaimy, Till Wissniowski, Vreni Schneider, Sebastian Mueller, Rudolf Brenneisen, Helmut K. Seitz, Matthias Ocker, Felix Stickel. Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis. Molecular Medicine 2011; 17(11-12): 1285 doi: 10.2119/molmed.2011.00149
|
| 21 |
Susanne Oesch, Jürg Gertsch. Cannabinoid receptor ligands as potential anticancer agents — high hopes for new therapies?. Journal of Pharmacy and Pharmacology 2009; 61(7): 839 doi: 10.1211/jpp.61.07.0002
|
| 22 |
Kathleen A. Russell. Caring for Patients Using Medical Marijuana. Journal of Nursing Regulation 2019; 10(3): 47 doi: 10.1016/S2155-8256(19)30148-6
|
| 23 |
Eric Mensah, Reza Tabrizchi, Noriko Daneshtalab. Pharmacognosy and Effects of Cannabinoids in the Vascular System. ACS Pharmacology & Translational Science 2022; 5(11): 1034 doi: 10.1021/acsptsci.2c00141
|
| 24 |
Yan Wei, Xiao-li Kang, Xu Wang. The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression. Experimental Biology and Medicine 2014; 239(2): 183 doi: 10.1177/1535370213514922
|
| 25 |
Julie Zhu, Kevork M Peltekian. Cannabis and the liver: Things you wanted to know but were afraid to ask. Canadian Liver Journal 2019; 2(3): 51 doi: 10.3138/canlivj.2018-0023
|
| 26 |
Yosefa Avraham, Johnny Amer, Sarit Doron, Lina Abu-Tair, Mahmud Mahamid, Areej Khatib, Elliot M. Berry, Rifaat Safadi. The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 302(12): G1364 doi: 10.1152/ajpgi.00191.2011
|
| 27 |
Nazar Pryimak, Mariia Zaiachuk, Olga Kovalchuk, Igor Kovalchuk. The Potential Use of Cannabis in Tissue Fibrosis. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.715380
|
| 28 |
Ralph-Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, Mohammad-Ali Jenabian, Cecilia T. Costiniuk. Cannabinoids and Chronic Liver Diseases. International Journal of Molecular Sciences 2022; 23(16): 9423 doi: 10.3390/ijms23169423
|
| 29 |
Wei Chen, Zhenhua Chen, Nina Xue, Zhibing Zheng, Song Li, LiLi Wang. Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 2013; 386(8): 721 doi: 10.1007/s00210-013-0875-y
|
| 30 |
Laurence Brunet, Erica E. M. Moodie, Kathleen Rollet, Curtis Cooper, Sharon Walmsley, Martin Potter, Marina B. Klein. Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis. Clinical Infectious Diseases 2013; 57(5): 663 doi: 10.1093/cid/cit378
|
| 31 |
Cecilia J. Sorensen, Kristen DeSanto, Laura Borgelt, Kristina T. Phillips, Andrew A. Monte. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review. Journal of Medical Toxicology 2017; 13(1): 71 doi: 10.1007/s13181-016-0595-z
|
| 32 |
Part I: Current Legislation, Scientific Literature Review, and Nursing Implications. Journal of Nursing Regulation 2018; 9(2): S6 doi: 10.1016/S2155-8256(18)30083-8
|
| 33 |
Puneet Puri, Arun J. Sanyal. Zakim and Boyer's Hepatology. 2012; : 941 doi: 10.1016/B978-1-4377-0881-3.00053-X
|
| 34 |
|
| 35 |
Eleonora Patsenker, Philip Sachse, Andrea Chicca, María Gachet, Vreni Schneider, Johan Mattsson, Christian Lanz, Mathias Worni, Andrea De Gottardi, Mariam Semmo, Jochen Hampe, Clemens Schafmayer, Rudolf Brenneisen, Jürg Gertsch, Felix Stickel, Nasser Semmo. Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation. International Journal of Molecular Sciences 2015; 16(4): 7057 doi: 10.3390/ijms16047057
|
| 36 |
Samar Rezq, Reham Hassan, Mona F. Mahmoud. Rimonabant ameliorates hepatic ischemia/reperfusion injury in rats: Involvement of autophagy via modulating ERK- and PI3K/AKT-mTOR pathways. International Immunopharmacology 2021; 100: 108140 doi: 10.1016/j.intimp.2021.108140
|
| 37 |
Ahmed ElTelbany, George Khoudari, Yasser Al-Khadra, Arthur McCullough, Naim Alkhouri. Lower Rates of Hepatocellular Carcinoma Observed Among Cannabis Users: A Population-Based Study. Cureus 2022; doi: 10.7759/cureus.24576
|
| 38 |
Massimo Pinzani, Jose Macias-Barragan. Update on the pathophysiology of liver fibrosis. Expert Review of Gastroenterology & Hepatology 2010; 4(4): 459 doi: 10.1586/egh.10.47
|
| 39 |
Madeline Manning Meurer, Kalyan Chakrala, Dinesh Gowda, Charles Burns, Randall Kelly, Natalia Schlabritz-Loutsevitch. A Case of Cannabinoid Hyperemesis Syndrome with Heliobacter Pylori and Preeclampsia during Pregnancy. Substance Abuse 2018; 39(1): 9 doi: 10.1080/08897077.2017.1356790
|
| 40 |
Sara Manti, Lucia Marseglia, Gabriella D Angelo, Martina Filippelli, Caterina Cuppari, Eloisa Gitto, Claudio Romano, Teresa Arrigo, Carmelo Salpietro. Portal Hypertension as Immune Mediate Disease. Hepatitis Monthly 2014; 14(5) doi: 10.5812/hepatmon.18625
|
| 41 |
Appendix C: References (Part I). Journal of Nursing Regulation 2018; 9(2): S52 doi: 10.1016/S2155-8256(18)30100-5
|
| 42 |
|
| 43 |
Ayman Alzu’bi, Mazhar Salim Al Zoubi, Bahaa Al-Trad, Manal Isam AbuAlArjah, Malek Shehab, Hiba Alzoubi, Dima Albals, Gamal T. Abdelhady, Waseem El-Huneidi. Acute Hepatic Injury Associated with Acute Administration of Synthetic Cannabinoid XLR-11 in Mouse Animal Model. Toxics 2022; 10(11): 668 doi: 10.3390/toxics10110668
|
| 44 |
P.N. Soares, R.A. Miranda, T.C. Peixoto, F.A.H. Caramez, D.S. Guarda, A.C. Manhães, E. de Oliveira, E.G. de Moura, P.C. Lisboa. Cigarette smoke during lactation in rat female progeny: Late effects on endocannabinoid and dopaminergic systems. Life Sciences 2019; 232: 116575 doi: 10.1016/j.lfs.2019.116575
|
| 45 |
Leontina-Elena Filipiuc, Raluca Ştefănescu, Carmen Solcan, Mitică Ciorpac, Andrei Szilagyi, Dana Cojocaru, Gabriela Dumitrita Stanciu, Ioana Creangă, Cătălin-Cezar Caratașu, Daniela-Carmen Ababei, Roxana-Elena Gavrila, Andrei-Daniel Timofte, Silviu-Iulian Filipiuc, Veronica Bild. Acute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified Cannabis sativa L. in Rodents. Pharmaceuticals 2023; 16(5): 694 doi: 10.3390/ph16050694
|
| 46 |
Ayman Alzu’bi, Fatimah Almahasneh, Ramada Khasawneh, Ejlal Abu-El-Rub, Worood Bani Baker, Raed M. Al-Zoubi. The synthetic cannabinoids menace: a review of health risks and toxicity. European Journal of Medical Research 2024; 29(1) doi: 10.1186/s40001-023-01443-6
|